Skip to main content
. 2023 Mar 16;18(3):e0282708. doi: 10.1371/journal.pone.0282708

Table 3. Median Ct values of nasal and saliva specimens stratified by days from symptom onset, and results from the Wilcoxon signed-rank tests for the overall analysis cohort.

n (Pairs) Nasal VTM Saliva Direct Wilcoxon signed-rank test
Days since symptom onset Median IQR Median IQR Median of differences Z p-value
Ct Ct
Less than 5 days 21 34.6 32.3–50.0 32.5 26.6–33.9 8.7 3.02 0.003
5 to 9 days 63 40.0 33.75–50.0 35.8 30.9–38.7 4.0 4.58 < 0.001
10 to 14 days 35 50.0 39.75–50.0 39.4 32.85–41.5 8.6 2.37 0.003
15 or more days 28 50.0 41.88–50.0 38.7 30.82–50.0 6.1 3.14 0.002